• Our Science
    • Nucleos(t)ides
    • Pipeline & Programs
  • Hepatitis C
    • Bemnifosbuvir + Ruzasvir
    • About Hepatitis C
  • About Atea
    • About Us
    • Leadership
    • Careers
    • Contact
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • Publications
    • Financials
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Info
      • Stock Quote & Chart
      • Historical Price Look Up
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Resources
      • Investor FAQS
      • Email Alerts
      • Contact IR
      • RSS Feeds

January 1, 2020

x

Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19

Back to All News

Atea is a clinical-stage biopharmaceutical company committed to addressing unmet medical needs through novel antiviral treatments.

  • Atea Pharmaceuticals, Inc.
  • 225 Franklin Street
  • Suite 2100
  • Boston, MA 02110
  • (857) 284-8891

Copyright © 2025 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use

BREAKING NEWS

Atea Pharmaceuticals announces strategic collaboration with Roche to develop and commercialize AT-527 for patients with COVID-19.

Read More Enter Site